caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1790746907

J Paul MarcouxMD

Medical OncologyBoston, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where J Paul Marcoux's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Nikhil Ramaiya
Diagnostic Radiology · West Palm Beach, FL
32119
Rachna Madan
Diagnostic Radiology · Boston, MA
31145
Francine Jacobson
Diagnostic Radiology · Roanoke, VA
29154
Jyothipriya Jagannathan
Diagnostic Radiology · Jamaica Plain, MA
2671
Lucian Chirieac
Pathology · Boston, MA
2265
Ritu Gill
Diagnostic Radiology · New York, NY
21100
Lynette Sholl
Pathology · Boston, MA
1849
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
1443
SAINANI, NISHA14138
Boston Public Health Commission
Ambulance Service Provider · Boston, MA
1338
MASS GENERAL BRIGHAM HOME CARE, INC.1182
KIM, CHUN1126
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
368
Beneficiaries
—
Total drug cost
$1.9M
Distinct drugs
16
Brand share
44.6%
Top prescribed drugs
Gabapentin55 claims
Osimertinib Mesylate45 claims
Dexamethasone44 claims
Ondansetron27 claims
Lorlatinib26 claims
QUALITY · MIPS · 2024
Final MIPS score
84.1
Quality
65.0
Cost
69.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.38%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
358
Unique beneficiaries
—
Total services
779
Distinct HCPCS
6
Medicare payment
$91K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 257 Medical Oncology providers in MA — top quintile (cohort median 290).